Cardiac tissue engineering promises to deliver new methods for repairing damaged myocardium following infarction and regenerating diseased myocardium resulting from maladaptive cardiac hypertrophy. We also envision that creating disease models in vitro will aid in understanding cardiac disease progression and pathophysiology. Further, this approach represents a way to simply and rapidly screen new cardiac pharmaceuticals to speed-up the drug discovery process, accelerating the time-to-market for new therapies.
Multiscale coupling in three dimensions remains a key problem in cardiac tissue engineering. Myocardium is a highly specialized tissue type requiring structure-function relationships to be preserved from ion channels and sarcomeres at the nano/micro scales to tissue and organ level function at the macroscale. Our research is focused in on engineering the cellular microenvironment to control myogenesis from the “bottom-up.” In other words, controlling assembly at the single-cell level combined with organized cell-cell organization and self-assembly through the tissue, organ and whole organism levels.
Primary Investigator: Adam W. Feinberg, Ph.D.
Muscular thin films (MTFs) are a biohybrid material that integrates a tissue engineered monolayer of cardiac muscle cells with a thin, elastic film. This biotic-abiotic composite combines advantages of both materials; mainly excellent contractile strength, spatial control of cell alignment from the micrometer to centimeter length scales and superb handling characteristics that allow the near limitless formation of different shapes. We have demonstrated that MTFs can be used to fabricate a variety of muscle powered actuators and devices. These “soft robotic” applications are an exciting proof-of-concept demonstration of how muscle can be utilized as a material for building many things. Just like muscle is the universal actuator in most large animals, muscle has the same potential to be used to power engineered systems where no synthetic alternative is available. See our Science paper on this topic.
Clinical applications remain the ultimate goal for MTFs where the ability to closely match wild-type (natural) muscle structure and function provides key advantages. First, the MTF can be used as a simple, biomechanical in vitro model for a laminar layer of the ventricular wall. While regenerating an entire heart likely lies many decades off in the future, we can build a single layer of the ventricle right now. Second, we are building MTFs that mimic both healthy and cardiomyopathic myocardium, evaluating the structural and functional differences between the two. Third, we are using these in vitro systems to evaluate drug effects on contractility to determine both toxicity and efficacy of current and future therapeutic compounds.
The role of vascular smooth muscle (VSM) is an important area of research for diseases ranging from heart attack and stroke to traumatic brain injury. MTFs can be built using VSM instead of cardiomyocytes, producing a powerful platform for in vitro studies of structure-function relationships in VSM pathophysiology. Current efforts are aimed at better understanding the mechanism behind vasospasm following subarachnoid hemorrhage and traumatic brain injury. This will serve as a test-bed for screening new therapeutic compounds as well as learning how current treatment paradigms affect VSM contractility.
Welcome Dr. Cera and Dr. Lee! April 3rd, 2017
The DBG would like to extend a warm welcome to our new postdoctoral fellows, Luca Cera & Keel Yong Lee. Luca comes to us from Berlin, German, where he recently completed his Ph.D. in Chemistry under the guidance of Prof. Dr. Christoph A. Schalley. Keel Yong recently completed his Ph.D. in Prof. Kwanwoo Shin’s lab at Sogang University in Seoul, South Korea. We are looking forward to expanding on our past collaborations with him.
Congratulations to Karaghen Hudson, Leila Deravi & Nina Sinatra on the cover of Macromolecular Materials and Engineering! March 27th, 2017
Parker Lab Artist Karaghen Hudson’s illustration accompanying Leila Deravi & Nina Sinatra’s paper “Design and Fabrication of Fibrous Nanomaterials Using Pull Spinning” was chosen for the March 2017 cover of Macromolecular Materials and Engineering.
Pull spinning is a new nanofiber manufacturing technique that uses a high-speed rotating bristle to draw anisotropic nanofibers from a polymer solution. The versatile structure and composition of scaffolds formed using pull spinning enables a wide range of applications, including muscle tissue engineering and textile design.
Congratulations to George Touloumes! March 21st, 2017
Congratulations to Parker Lab PhD student George Touloumes who has been awarded an NSF Graduate Research Fellowship.
Congratulations to Ben Pope! March 21st, 2017
Congratulations to Parker Lab Postdoc Ben Pope who was recently awarded a Life Sciences Research Foundation Fellowship sponsored by the Good Ventures Foundation.
Congratulations Grant Gonzalez and Michael Rosnach on the cover of Macromolecular Materials and Engineering! January 23rd, 2017
Parker Lab Artist Michael Rosnach’s illustration accompanying PhD Student Grant Gonzalez’s paper “Production of synthetic, para-aramid and biopolymer nanofibers by immersion rotary jet-spinning” was chosen for the January 2017 cover of Macromolecular Materials and Engineering.
“Utilizing a precipitant vortex, a novel nanofiber platform produces Kevlar, nylon, DNA, and alginate nanofibers for high-performance composites and tissue engineering applications.”